Loading...
Loading...
Analysts at Piper Jaffray downgraded
Mirati Therapeutics, Inc. MRTX from Overweight to Neutral. The target price for Mirati Therapeutics has been lowered from $50 to $45. Mirati Therapeutics shares closed at $44.34 on Wednesday.
Analysts at Macquarie downgraded
StarzSTRZA from undefined to Neutral. Starz shares closed at $40.44 on Wednesday.
Analysts at UBS downgraded
Natural Resource Partners LPNRP from Neutral to Sell. The target price for Natural Resources is set to $2.50. Natural Resources shares closed at $2.97 on Wednesday.
BB&T Capital downgraded
Accuride CorporationACW to Hold. Accuride shares closed at $3.29 on Wednesday.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in